313 related articles for article (PubMed ID: 28669538)
1. The Effect of Methylphenidate on the Microstructure of Schedule-Induced Polydipsia in an animal model of ADHD.
Íbias J; Daniels CW; Miguéns M; Pellón R; Sanabria F
Behav Brain Res; 2017 Aug; 333():211-217. PubMed ID: 28669538
[TBL] [Abstract][Full Text] [Related]
2. A microstructural analysis of schedule-induced polydipsia reveals incentive-induced hyperactivity in an animal model of ADHD.
Íbias J; Pellón R; Sanabria F
Behav Brain Res; 2015 Feb; 278():417-23. PubMed ID: 25447297
[TBL] [Abstract][Full Text] [Related]
3. Effects of dopamine agents on a schedule-induced polydipsia procedure in the spontaneously hypertensive rat and in Wistar control rats.
Íbias J; Miguéns M; Pellón R
J Psychopharmacol; 2016 Sep; 30(9):856-66. PubMed ID: 27296274
[TBL] [Abstract][Full Text] [Related]
4. Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.
Somkuwar SS; Kantak KM; Dwoskin LP
J Neurosci Methods; 2015 Aug; 252():55-63. PubMed ID: 25680322
[TBL] [Abstract][Full Text] [Related]
5. Schedule-induced polydipsia in the spontaneously hypertensive rat and its relation to impulsive behaviour.
Ibias J; Pellón R
Behav Brain Res; 2011 Sep; 223(1):58-69. PubMed ID: 21540060
[TBL] [Abstract][Full Text] [Related]
6. Adolescent methylphenidate treatment differentially alters adult impulsivity and hyperactivity in the Spontaneously Hypertensive Rat model of ADHD.
Somkuwar SS; Kantak KM; Bardo MT; Dwoskin LP
Pharmacol Biochem Behav; 2016 Feb; 141():66-77. PubMed ID: 26657171
[TBL] [Abstract][Full Text] [Related]
7. Effects of methylphenidate on attentional set-shifting in a genetic model of attention-deficit/hyperactivity disorder.
Cao AH; Yu L; Wang YW; Wang JM; Yang LJ; Lei GF
Behav Brain Funct; 2012 Feb; 8(1):10. PubMed ID: 22369105
[TBL] [Abstract][Full Text] [Related]
8. Strain differences in self-administration of methylphenidate and sucrose pellets in a rat model of attention-deficit hyperactivity disorder.
Marusich JA; McCuddy WT; Beckmann JS; Gipson CD; Bardo MT
Behav Pharmacol; 2011 Dec; 22(8):794-804. PubMed ID: 22015805
[TBL] [Abstract][Full Text] [Related]
9. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder.
van den Bergh FS; Bloemarts E; Chan JS; Groenink L; Olivier B; Oosting RS
Pharmacol Biochem Behav; 2006 Mar; 83(3):380-90. PubMed ID: 16580713
[TBL] [Abstract][Full Text] [Related]
10. Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments.
Jordan CJ; Harvey RC; Baskin BB; Dwoskin LP; Kantak KM
Drug Alcohol Depend; 2014 Jul; 140():25-32. PubMed ID: 24811203
[TBL] [Abstract][Full Text] [Related]
11. The spontaneously hypertensive rat/Izm (SHR/Izm) shows attention deficit/hyperactivity disorder-like behaviors but without impulsive behavior: therapeutic implications of low-dose methylphenidate.
Kishikawa Y; Kawahara Y; Yamada M; Kaneko F; Kawahara H; Nishi A
Behav Brain Res; 2014 Nov; 274():235-42. PubMed ID: 25151620
[TBL] [Abstract][Full Text] [Related]
12. Chronic Methylphenidate Alters Tonic and Phasic Glutamate Signaling in the Frontal Cortex of a Freely-Moving Rat Model of ADHD.
Miller EM; Quintero JE; Pomerleau F; Huettl P; Gerhardt GA; Glaser PEA
Neurochem Res; 2019 Jan; 44(1):89-101. PubMed ID: 29397534
[TBL] [Abstract][Full Text] [Related]
13. Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.
Umehara M; Ago Y; Kawanai T; Fujita K; Hiramatsu N; Takuma K; Matsuda T
Behav Pharmacol; 2013 Aug; 24(4):328-31. PubMed ID: 23751518
[TBL] [Abstract][Full Text] [Related]
14. Different relations between schedule-induced polydipsia and impulsive behaviour in the Spontaneously Hypertensive Rat and in high impulsive Wistar rats: questioning the role of impulsivity in adjunctive behaviour.
Ibias J; Pellón R
Behav Brain Res; 2014 Sep; 271():184-94. PubMed ID: 24931797
[TBL] [Abstract][Full Text] [Related]
15. Methylphenidate reduces impulsive behaviour in juvenile Wistar rats, but not in adult Wistar, SHR and WKY rats.
Bizot JC; Chenault N; Houzé B; Herpin A; David S; Pothion S; Trovero F
Psychopharmacology (Berl); 2007 Aug; 193(2):215-23. PubMed ID: 17406857
[TBL] [Abstract][Full Text] [Related]
16. Extinction learning deficit in a rodent model of attention-deficit hyperactivity disorder.
Brackney RJ; Cheung TH; Herbst K; Hill JC; Sanabria F
Behav Brain Funct; 2012 Dec; 8():59. PubMed ID: 23237608
[TBL] [Abstract][Full Text] [Related]
17. Baseline behavior, but not sensitivity to stimulant drugs, differs among spontaneously hypertensive, Wistar-Kyoto, and Sprague-Dawley rat strains.
Ferguson SA; Paule MG; Cada A; Fogle CM; Gray EP; Berry KJ
Neurotoxicol Teratol; 2007; 29(5):547-61. PubMed ID: 17689921
[TBL] [Abstract][Full Text] [Related]
18. Impact of developmental exposure to methylphenidate on rat brain's immune privilege and behavior: Control versus ADHD model.
Coelho-Santos V; Cardoso FL; Leitão RA; Fontes-Ribeiro CA; Silva AP
Brain Behav Immun; 2018 Feb; 68():169-182. PubMed ID: 29061363
[TBL] [Abstract][Full Text] [Related]
19. The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior.
Wultz B; Sagvolden T; Moser EI; Moser MB
Behav Neural Biol; 1990 Jan; 53(1):88-102. PubMed ID: 2302145
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics study of the prefrontal cortex in a rat model of attention deficit hyperactivity disorder reveals the association between cholesterol metabolism disorder and hyperactive behavior.
Chen T; Yuan H; Sun YB; Song YC; Lu M; Ni X; Han X
Biochem Biophys Res Commun; 2020 Mar; 523(2):315-321. PubMed ID: 31864712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
